Use of Predigraft in Kidney Transplant Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

May 25, 2025

Study Completion Date

May 25, 2025

Conditions
Kidney Transplant
Interventions
DEVICE

Predigraft group

"Patients in the interventional arm will use Predigraft (Class 1 medical device under MDD 93/42/EEC Cibiltech Society) to receive therapeutic education content (videos, facts sheets, short messages, questionnaires), exchange documents with their doctors and interact via messaging with them.~Physicians will be able to calculate their iBox score to predict their patients' allograft survival at 3, 5 and 7 years."

Trial Locations (2)

Unknown

Hopital Necker - APHP, Paris

Hopital Saint Louis - APHP, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER